Pictet Asset Management Holding SA Buys 825 Shares of Dolby Laboratories, Inc. (NYSE:DLB)

featured-image

Pictet Asset Management Holding SA lifted its stake in Dolby Laboratories, Inc. (NYSE:DLB – Free Report) by 10.5% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 8,673 shares of the electronics maker’s stock after acquiring an additional 825 shares during [...]

Pictet Asset Management Holding SA lifted its stake in Dolby Laboratories, Inc. ( NYSE:DLB – Free Report ) by 10.5% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission.

The institutional investor owned 8,673 shares of the electronics maker’s stock after acquiring an additional 825 shares during the period. Pictet Asset Management Holding SA’s holdings in Dolby Laboratories were worth $677,000 at the end of the most recent quarter. A number of other hedge funds have also recently made changes to their positions in the stock.



Fifth Third Bancorp boosted its holdings in shares of Dolby Laboratories by 82.7% in the 4th quarter. Fifth Third Bancorp now owns 360 shares of the electronics maker’s stock valued at $28,000 after buying an additional 163 shares in the last quarter.

Nisa Investment Advisors LLC lifted its position in Dolby Laboratories by 436.2% during the fourth quarter. Nisa Investment Advisors LLC now owns 370 shares of the electronics maker’s stock valued at $29,000 after acquiring an additional 301 shares during the last quarter.

Mather Group LLC. boosted its stake in Dolby Laboratories by 36.8% in the fourth quarter.

Mather Group LLC. now owns 528 shares of the electronics maker’s stock valued at $41,000 after acquiring an additional 142 shares in the last quarter. GAMMA Investing LLC grew its holdings in Dolby Laboratories by 207.

5% in the fourth quarter. GAMMA Investing LLC now owns 778 shares of the electronics maker’s stock worth $61,000 after purchasing an additional 525 shares during the last quarter. Finally, Wealthfront Advisers LLC acquired a new position in shares of Dolby Laboratories during the fourth quarter worth $94,000.

58.56% of the stock is currently owned by hedge funds and other institutional investors. Dolby Laboratories Price Performance Shares of DLB opened at $70.

09 on Tuesday. The firm has a market capitalization of $6.69 billion, a PE ratio of 25.

77 and a beta of 0.94. The company’s fifty day moving average price is $81.

81 and its 200-day moving average price is $78.54. Dolby Laboratories, Inc.

has a 1-year low of $66.35 and a 1-year high of $89.66.

Dolby Laboratories Dividend Announcement Insider Transactions at Dolby Laboratories In other news, CAO Ryan Nicholson sold 7,000 shares of the stock in a transaction on Wednesday, February 5th. The shares were sold at an average price of $84.07, for a total value of $588,490.

00. Following the sale, the chief accounting officer now owns 29,758 shares in the company, valued at $2,501,755.06.

This represents a 19.04 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website .

Also, EVP Mark Andrew Sherman sold 40,000 shares of the business’s stock in a transaction on Thursday, January 30th. The shares were sold at an average price of $84.88, for a total transaction of $3,395,200.

00. Following the transaction, the executive vice president now owns 62,397 shares of the company’s stock, valued at $5,296,257.36.

This represents a 39.06 % decrease in their ownership of the stock. The disclosure for this sale can be found here .

Insiders sold a total of 65,121 shares of company stock worth $5,501,324 over the last three months. 38.39% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades A number of analysts have recently weighed in on the company. Rosenblatt Securities reissued a “buy” rating and issued a $100.00 price objective on shares of Dolby Laboratories in a research report on Thursday, January 30th.

Barrington Research reissued an “outperform” rating and issued a $100.00 price target on shares of Dolby Laboratories in a report on Thursday, February 13th. Finally, StockNews.

com downgraded shares of Dolby Laboratories from a “strong-buy” rating to a “buy” rating in a report on Friday, January 31st. View Our Latest Analysis on DLB Dolby Laboratories Company Profile ( Free Report ) Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.

Recommended Stories Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter ..